Managing Trace Elements in Parenteral Nutrition
A new website providing educational content and treatment guidelines
Dedicated to Alleviating Drug Shortages
We are committed to collaborating with the FDA to prevent or mitigate drug shortages that impact the health of patients.
Check Product Availability
Updated October 1, 2023
HydrALAZINE Hydrochloride
- 20 mg/mL | 1 mL Single Dose Vial
- Shelf Pack — 25
Papaverine HCL
- 30 mg/mL | 2 mL Single Dose Vial
- Shelf Pack — 25
Zinc Sulfate
- 5 mg/mL | 5 mL Pharmacy Bulk Package Vial
- Shelf Pack — 25
News Center
American Regent Receives 2023 Novaplus Program Excellence Award from Vizient
Shirley, NY – September 27, 2023:
American Regent has received a Novaplus Program Excellence Award from Vizient, Inc., the nation’s largest provider-driven health care performance improvement company. The recognition was announced at the 2023 Vizient Connections Summit, held September 18-21 in Las Vegas.
INJECTAFER® Approved in the U.S. for the Treatment of Iron Deficiency in Adult Patients with Heart Failure
Basking Ridge, NJ and Shirley, NY – June 5, 2023: Daiichi Sankyo, Inc. and American Regent, Inc., a Daiichi Sankyo Group company, today announced that the U.S. Food and Drug Administration (FDA) approved INJECTAFER® (ferric carboxymaltose injection) for the treatment of iron deficiency in adult patients with heart failure categorized as New York Heart Association class II/III to improve exercise capacity.
St. John’s University and American Regent Post-Doctoral Pharmaceutical Industry Fellowship Now Recruiting
Melville, NY – September 14, 2023:
Learn more about the St. John’s University and American Regent Post-Doctoral Pharmaceutical Industry Fellowship by downloading our brochure. Information on how to apply to our program as well as key deadlines are included.